MISHIMA Yuko | Division of Clinical Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Resear
スポンサーリンク
概要
- 同名の論文著者
- Division of Clinical Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Researの論文著者
関連著者
-
Hatake Kiyohiko
Department Of Medical Oncology Cancer Institute Hospital Of Japanese Foundation For Cancer Research
-
Mishima Yuko
Cancer Chemotherapy Center Clinical Chemotherapy Japanese Foundation For Cancer Research
-
Matsumoto-mishima Yuko
癌研究会癌化学療法センター 臨床研究部
-
Terui Yasuhito
Department Of Medical Oncology Cancer Institute Hospital Of Japanese Foundation For Cancer Research
-
Terui Yasuhito
Division Of Hemopoiesis Institute Of Hematology Jichi Medical School
-
Terui Yasuhito
Department Of Medical Oncology And Hematology Cancer Institute Hospital
-
Hatake Kiyohiko
Division Of Medical Oncology Cancer Institute Hospital
-
MISHIMA Yuko
Division of Clinical Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Resear
-
Morishima Yasuo
Department Of Hematology And Chemotherapy
-
Hatake Kiyohiko
Olympus Bio-imaging Laboratory The Cancer Chemotherapy Center Of The Jfcr
-
三木 義男
癌研ゲノムセンター
-
Shiba T
Department Of Medical Oncology The Cancer Institute Of Japanese Foundation For Cancer Research
-
Yoshimoto M
The Cancer Institute Of Japanese Foundation For Cancer Research (jfcr)
-
Kobayashi Takayuki
Cancer Inst. Hospital Tokyo Jpn
-
Takahashi Shunji
Cancer Inst. Hospital Tokyo Jpn
-
Sato Takaaki
Division Of Surgery Tochigi Cancer Center Hospital
-
TAKAHASHI Shunji
Division of Clinical Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Resear
-
ITO Yoshinori
Division of Clinical Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Resear
-
SUGIMURA Natsuhiko
OLYMPUS Bio-Imaging Laboratory, Japanese Foundation for Cancer Research
-
ROKUDAI Akiko
Cancer Chemotherapy Center, Clinical Chemotherapy, Japanese Foundation for Cancer Research
-
KUNIYOSHI Ryoko
Cancer Chemotherapy Center, Clinical Chemotherapy, Japanese Foundation for Cancer Research
-
ROKUDAI Akiko
Division of Clinical Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Resear
-
KUNIYOSHI Ryoko
Division of Clinical Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Resear
-
MISHIMA Yuji
Division of Clinical Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Resear
-
AIZU-YOKOTA Eriko
Department of Biochemistry, Kyoritsu University of Pharmacy
-
SONODA Yoshiko
Department of Biochemistry, Kyoritsu University of Pharmacy
-
KASAHARA Tadashi
Department of Biochemistry, Kyoritsu University of Pharmacy
-
SAKURAI Takuma
Division of Clinical Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Resear
-
MISHIMA Yuji
Olympus Bio-Imaging Laboratory, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research
-
SASAOKA Chino
Olympus Bio-Imaging Laboratory, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research
-
KOJIMA Kiyotsugu
Olympus Bio-Imaging Laboratory, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research
-
YOKOYAMA Masahiro
Division of Clinical Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Resear
-
MIZUNUMA Nobuyuki
Division of Clinical Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Resear
-
Ito Yoshinori
Department Of Medical Oncology The Cancer Institute Of Japanese Foundation For Cancer Research
-
Shiba Tadayoshi
Department Of Molecular Biology Kitasato University
-
Ito Yoshinori
Department Of Medical Oncology Cancer Institute Hospital Japanese Foundation For Cancer Research
-
Aizu‐yokota E
Department Of Biochemistry Kyoritsu University Of Pharmacy
-
Takahashi Shunji
Department Of Oncology And Hematology Cancer Institute Hospital
-
Sasaoka Chino
Olympus Bio-imaging Laboratory Cancer Chemotherapy Center Japanese Foundation For Cancer Research
-
Sonoda Y
Department Of Biochemistry Kyoritsu University Of Pharmacy
-
Sonoda Yoshiko
Department Of Biochemistry And Immunology Kyoritsu University Of Pharmacy
-
Sakurai Takuma
Division Of Clinical Chemotherapy Cancer Chemotherapy Center Japanese Foundation For Cancer Research
-
Mizunuma Nobuyuki
Department Of Medical Oncology Cancer Institute Hospital Of Japanese Foundation For Cancer Research
-
Mizunuma Nobuyuki
Department Of Medical Oncology Cancer Institute Hospital
-
Yokoyama Masahiro
Department Of Oncology And Hematology Cancer Institute Hospital
-
Kasahara T
Department Of Biochemistry Kyoritsu University Of Pharmacy
-
Kasahara Tadashi
Department Of Biochemistry And Immunology Kyoritsu University Of Pharmacy
-
Takahashi Shunji
Division Of Clinical Chemotherapy Cancer Chemotherapy Center Japanese Foundation For Cancer Research
-
Kuniyoshi Ryoko
Department Of Clinical Chemotherapy Cancer Chemotherapy Center Japanese Foundation For Cancer Resear
-
Tsukahara Satomi
Department Of Medical Oncology Cancer Institute Hospital Japanese Foundation For Cancer Research
-
Tsukahara Satomi
Department Of Medical Oncology The Cancer Institute Of Japanese Foundation For Cancer Research
-
Ito Yoshinori
Department Of Medical Oncology Cancer Institute Hospital Of Japanese Foundation For Cancer Research
-
Takahashi Kaoru
Department Of Breast Oncology Cancer Institute Hospital Of Japanese Foundation For Cancer Research
-
Sugimura Natsuhiko
Olympus Bio-imaging Laboratory Japanese Foundation For Cancer Research
-
Ito Yoshinori
Departments Of Pathology Medical Oncology And Breast Oncology The Cancer Institute Hospital Of The J
-
Ito Yoshinori
Division Of Central Clinical Laboratory Nagoya City University Hospital
-
Kojima Kiyotsugu
Olympus Bio-imaging Laboratory Cancer Chemotherapy Center Japanese Foundation For Cancer Research
-
Takagi Koichi
Department Of Medical Oncology Cancer Institute Hospital Of Japanese Foundation For Cancer Research
-
Ito Yoshinori
Department Of Breast Oncology The Cancer Institute Hospital Of The Japanese Foundation For Cancer Research
著作論文
- Differential Regulation of Eotaxin-1/CCL11 and Eotaxin-3/CCL26 Production by the TNF-α and IL-4 Stimulated Human Lung Fibroblast(Pharmacology)
- Blockade of bulky lymphoma-associated CD55 expression by RNA interference overcomes resistance to complement-dependent cytotoxicity with rituximab